Glycosylation End Products, Advanced

Known as: Advanced Glycation End Products, Advanced Glycation End-Product, Advanced Glycation Endproducts 
Products derived from the nonenzymatic reaction of GLUCOSE and PROTEINS in vivo that exhibit a yellow-brown pigmentation and an ability to… (More)
National Institutes of Health

Related topics

Related topics

11 relations
Diabetes MellitusIn BloodProcess of secretionagonists
(More)

Narrower (1)

glucosepane

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Alzheimer's disease as an inflammatory disease.
Alzheimer's disease (AD) is a neurodegenerative condition characterized by the formation of amyloid-β plaques, aggregated and… (More)
  • figure 1
Is this relevant?
Review
2016
Review
2016
Uremic Toxicity of Advanced Glycation End Products in CKD.
Advanced glycation end products (AGEs), a heterogeneous group of compounds formed by nonenzymatic glycation reactions between… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 1
Is this relevant?
Review
2006
Review
2006
Advanced glycation end products: sparking the development of diabetic vascular injury.
Advanced glycation end products (AGEs) are proteins or lipids that become glycated after exposure to sugars. AGEs are prevalent… (More)
Is this relevant?
Review
2005
Review
2005
Understanding RAGE, the receptor for advanced glycation end products
Advanced glycation end products (AGEs), S100/calgranulins, HMGB1-proteins, amyloid-β peptides, and the family of β-sheet fibrils… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Improved arterial compliance by a novel advanced glycation end-product crosslink breaker.
BACKGROUND Arterial stiffening with increased pulse pressure is a leading risk factor for cardiovascular disease in the elderly… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Review
2000
Review
2000
The biology of the receptor for advanced glycation end products and its ligands.
Receptor for advanced glycation end products (RAGE) is a multiligand member of the immunoglobulin superfamily of cell surface… (More)
Is this relevant?
Review
1999
Review
1999
Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis.
Receptor for advanced glycation end products (RAGE) is a member of the immunoglobulin superfamily of cell surface molecules and… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
1995
Review
1995
Advanced protein glycosylation in diabetes and aging.
Products of advanced protein glycosylation (advanced glycation end products, or AGEs) accumulate in tissues as a function of time… (More)
Is this relevant?
Highly Cited
1994
Highly Cited
1994
Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins.
Attack by reactive oxygen intermediates, common to many kinds of cell/tissue injury, has been implicated in the development of… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
Is this relevant?
Highly Cited
1991
Highly Cited
1991
Advanced glycosylation end products in patients with diabetic nephropathy.
BACKGROUND Glucose reacts nonenzymatically with proteins in vivo, chemically forming covalently attached glucose-addition… (More)
Is this relevant?